Clozapine is a powerful antipsychotic medication used to treat schizophrenia when other medications have not worked. It can be highly effective for people who have not responded to standard treatments. However, clozapine carries a rare but serious risk of lowering your white blood cell count.
This condition is called agranulocytosis, and it can leave your body unable to fight infections. Because of this risk, anyone taking clozapine must have regular blood tests to monitor their white blood cell levels. This monitoring is not optional. It is required by the FDA to keep patients safe while they benefit from this important medication.
Clozapine therapy monitoring involves checking your White Blood Cell Count at specific intervals throughout your treatment. In the first six months, you will need weekly testing. After that, testing frequency can decrease to every two weeks, then monthly. If your white blood cell count drops too low, your doctor will stop the medication immediately to prevent serious complications.